For: | Mancuso A. Budd-Chiari syndrome management: Lights and shadows. World J Hepatology 2011; 3(10): 262-264 [PMID: 22059108 DOI: 10.4254/wjh.v3.i10.262] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v3/i10/262.htm |
Number | Citing Articles |
1 |
Andrea Mancuso. Budd-chiari syndrome management: Timing of treatment is an open issue. Hepatology 2014; 59(3): 1213 doi: 10.1002/hep.26619
|
2 |
Andrea Mancuso. Management of Budd–Chiari syndrome in children. European Journal of Gastroenterology & Hepatology 2015; 27(1): 107 doi: 10.1097/MEG.0000000000000232
|
3 |
Andrea Mancuso. Budd–Chiari Syndrome Management: Controversies and Open Issues. Diagnostics 2022; 12(11): 2670 doi: 10.3390/diagnostics12112670
|
4 |
Andrea Mancuso. Management of portal vein thrombosis in cirrhosis: an update. European Journal of Gastroenterology & Hepatology 2016; 28(7): 739 doi: 10.1097/MEG.0000000000000633
|
5 |
S. Rajesh, Amar Mukund, Ankur Arora. Imaging Diagnosis of Splanchnic Venous Thrombosis. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/101029
|
6 |
Andrea Mancuso. An update on the management of Budd–Chiari syndrome. European Journal of Gastroenterology & Hepatology 2015; 27(3): 200 doi: 10.1097/MEG.0000000000000282
|
7 |
Lina I. Arcila-Garcés, José D. Correa-Vargas, Camila Guerrero-Bermúdez, Mariana Vélez-Marín. Manejo de pacientes con síndrome de Budd-Chiari. Revisión de tema. Hepatología 2020; : 55 doi: 10.52784/27112330.115
|
8 |
Andrea Mancuso. An update on management of Budd-Chiari syndrome. Annals of Hepatology 2014; 13(3): 323 doi: 10.1016/S1665-2681(19)30860-9
|
9 |
Andrea Mancuso. Focusing the Controversies in Budd-Chiari Syndrome Management. The International Journal of Gastroenterology and Hepatology Diseases 2022; 1(1) doi: 10.2174/2666290601666210406162525
|
10 |
A. Mancuso. Letter: management of portal vein thromboses in cirrhosis. Alimentary Pharmacology & Therapeutics 2015; 41(7): 698 doi: 10.1111/apt.13103
|
11 |
Andrea Mancuso. TIPS for Budd–Chiari syndrome: time to anticipate treatment. Liver International 2014; 34(7) doi: 10.1111/liv.12544
|
12 |
Tatiana M Reshetnyak, Natalia V Seredavkina, Maria A Satybaldyeva, Evgeniy L Nasonov, Vasiliy I Reshetnyak. Liver transplantation in a patient with primary antiphospholipid syndrome and Budd-Chiari syndrome. World Journal of Hepatology 2015; 7(19): 2229-2236 doi: 10.4254/wjh.v7.i19.2229
|
13 |
M.V. Catalina-Rodríguez, F. Díaz-Fontena. Protocolo diagnóstico y tratamiento del síndrome de Budd-Chiari primario. Medicine - Programa de Formación Médica Continuada Acreditado 2012; 11(12): 723 doi: 10.1016/S0304-5412(12)70373-6
|
14 |
Tanya M Pavri, Alan Herbst, Rajender Reddy, Kimberly A Forde. Budd-Chiari syndrome: A single-center experience. World Journal of Gastroenterology 2014; 20(43): 16236-16244 doi: 10.3748/wjg.v20.i43.16236
|
15 |
Martin Rössle. Interventional Treatment of Budd–Chiari Syndrome. Diagnostics 2023; 13(8): 1458 doi: 10.3390/diagnostics13081458
|
16 |
Andrea Mancuso. Timing of transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: An Italian hepatologist’s perspective. Journal of Translational Internal Medicine 2017; 5(4): 194 doi: 10.1515/jtim-2017-0033
|
17 |
A. Mancuso. Letter: target of TIPSS for Budd–Chiari syndrome should be avoiding liver transplant. Alimentary Pharmacology & Therapeutics 2014; 39(11): 1342 doi: 10.1111/apt.12738
|
18 |
Andrea Mancuso. Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation. Current Hepatology Reports 2017; 16(2): 158 doi: 10.1007/s11901-017-0344-z
|
19 |
Vasiliy I. Reshetnyak, Igor V. Maev, Tatiana M. Reshetnyak, Sergei V. Zhuravel, Vladimir M. Pisarev. Liver Disease and Hemostasis (Review) Part 2. Cholestatic Liver Disease and Hemostasis. General Reanimatology 2019; 15(6): 80 doi: 10.15360/1813-9779-2019-6-80-93
|
20 |
Akash Shukla, Abhishek Sadalage, Deepak Gupta, Amit Gupte, Anupam Mahapatra, Dipendu Mazumder, Chirag Shah, Tejas Modi, Megha Meshram, Prashant Dhore, Shobna Bhatia. Pregnancy outcomes in women with Budd Chiari Syndrome before onset of symptoms and after treatment. Liver International 2018; 38(4): 754 doi: 10.1111/liv.13552
|
21 |
Andrea Mancuso. Budd-Chiari syndrome hemodynamic: Clinical setting more complicated than computational model. Medical Engineering & Physics 2019; 71: 1 doi: 10.1016/j.medengphy.2019.06.021
|
22 |
Tetsuya Shimizu, Masato Yoshioka, Junji Ueda, Mampei Kawashima, Toshiyuki Irie, Yoichi Kawano, Akira Matsushita, Nobuhiko Taniai, Yasuhiro Mamada, Hiroshi Yoshida. Stenting of Inferior Right Hepatic Vein in a Patient with Budd-Chiari Syndrome: A Case Report. Journal of Nippon Medical School 2024; 91(1): 119 doi: 10.1272/jnms.JNMS.2023_90-603
|
23 |
Andrea Mancuso, Luigi Martinelli, Luciano De Carlis, Antonio Gaetano Rampoldi, Giovanni Magenta, Aldo Cannata, Luca Saverio Belli. A caval homograft for Budd-Chiari syndrome due to inferior vena cava obstruction. World Journal of Hepatology 2013; 5(5): 292-295 doi: 10.4254/wjh.v5.i5.292
|
24 |
Faisal Khan, Homoyon Mehrzad, Dhiraj Tripathi. Timing of transjugular intrahepatic portosystemic stent-shunt in Budd–Chiari syndrome: A UK hepatologist's perspective. Journal of Translational Internal Medicine 2018; 6(3): 97 doi: 10.2478/jtim-2018-0022
|
25 |
Faisal Khan, Matthew J. Armstrong, Homoyon Mehrzad, Frederick Chen, Desley Neil, Rachel Brown, Owen Cain, Dhiraj Tripathi. Review article: a multidisciplinary approach to the diagnosis and management of Budd‐Chiari syndrome. Alimentary Pharmacology & Therapeutics 2019; 49(7): 840 doi: 10.1111/apt.15149
|
26 |
Andrea Mancuso. The ischemic liver cirrhosis theory and its clinical implications. Medical Hypotheses 2016; 94: 4 doi: 10.1016/j.mehy.2016.06.008
|
27 |
Andrea Mancuso. Management of Suprahepatic Inferior Vena Cava Obstruction. CardioVascular and Interventional Radiology 2016; 39(11): 1665 doi: 10.1007/s00270-016-1446-7
|
28 |
Tarek Abdelazeem Sabra, Hideaki Okajima, Tetsuya Tajima, Ken Fukumitsu, Koichiro Hata, Kentaro Yasuchika, Toshihiko Masui, Kojiro Taura, Toshimi Kaido, Shinji Uemoto. Living donor liver transplantation for adult Budd Chiari syndrome – Resection without replacement of retrohepatic IVC: A case report. International Journal of Surgery Case Reports 2018; 42: 50 doi: 10.1016/j.ijscr.2017.11.050
|
29 |
|
30 |
Periasamy Uvaraj, Ramar Rathisharmila, Veerappan Ilamaran. Protein C and protein S deficiency presenting as Budd-Chiari syndrome. Blood Coagulation & Fibrinolysis 2013; 24(6): 652 doi: 10.1097/MBC.0b013e3283609972
|
31 |
A. Mancuso. Letter: why treatments of hepatitis C virus are less effective in cirrhosis. Alimentary Pharmacology & Therapeutics 2015; 41(7): 707 doi: 10.1111/apt.13118
|
32 |
Tomáš Grus, Lukáš Lambert, Gabriela Grusová, Rohan Banerjee, Andrea Burgetová. Budd-Chiari Syndrome. Prague Medical Report 2017; 118(2-3): 69 doi: 10.14712/23362936.2017.6
|
33 |
Emily Lin, Charles Bratton, Minh-Tri Nguyen, Joshua Chung, Michael De Vera, Mina Rakoski. Combined coronary artery bypass graft and liver/kidney transplantation in a liver failure patient with acute on chronic kidney failure and antiphospholipid syndrome. American Journal of Transplantation 2022; 22(10): 2464 doi: 10.1111/ajt.17067
|
34 |
Andrea Mancuso. Outcome of Budd–Chiari syndrome in Behçet׳s syndrome. Seminars in Arthritis and Rheumatism 2015; 45(1): e1 doi: 10.1016/j.semarthrit.2015.04.004
|